This is a medium to long term speculative stock and should be treated as such. Only invest what you are willing to lose and disregard the daily blips as they are just daytraders moving into and then out of the stock when they realise there's not a quick buck to be made. Once clinical trials advance we will soon know the fate of our investments, until then sit tight and wait.
